HCPCS Level IIdrugActive
J9395
Injection, fulvestrant
BETOS: O1E
Effective: 2004-01-01
Description
Injection, fulvestrant, 25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Fulvestrant
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
25 MG
Billing Units
10.0000
21
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.